Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Theoretical Basis for Refractive Index Changes Resulting from Solution Phase Molecular Interaction.

The journal of physical chemistry. B·2025
Same author

Assessing the clinical utility of biomarkers using the intervention probability curve (IPC).

Cancer biomarkers : section A of Disease markers·2023
Same author

Improving lung cancer diagnosis with cancer, fungal, and imaging biomarkers.

The Journal of thoracic and cardiovascular surgery·2023
Same author

Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination.

ACS omega·2022
Same author

Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.

American journal of respiratory and critical care medicine·2021
Same author

Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding.

Lipids in health and disease·2021
Same journal

The ACS at 150: The History of Analytical Chemistry Publications and a Century of Progress.

Analytical chemistry·2026
Same journal

Machine Learning-Enabled Image Analysis of Complex Chemical Mixtures: Synthetic Urine Droplets as a Test System.

Analytical chemistry·2026
Same journal

H<sub>2</sub>O<sub>2</sub>/Viscosity Tandem-Locked Fluorescent Probes Based on an In Situ Fluorophore Synthesis Strategy for Colitis Imaging and Diagnosis.

Analytical chemistry·2026
Same journal

TopoStitcher: A Geometric-Topological Structure-Guided Stitching Framework for Single-Molecule Localization Microscopy.

Analytical chemistry·2026
Same journal

Noninvasive SERS Immunosensing of Tyrosinase for Melanoma Monitoring via Microneedle Sampling Integrated with Satellite-Structured Bifunctional Nanozymes.

Analytical chemistry·2026
Same journal

Label-Free Electrochemical CRISPR Platform Gated by Allosteric Transcription Factors for Ultrasensitive Small-Molecule Detection.

Analytical chemistry·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

High Speed Sub-GHz Spectrometer for Brillouin Scattering Analysis
13:31

High Speed Sub-GHz Spectrometer for Brillouin Scattering Analysis

Published on: December 22, 2015

14.6K

Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering

Ian R Olmsted1, Mohamed Hassanein, Amanda Kussrow

  • 1Department of Chemistry and the Vanderbilt Institute of Chemical Biology, Vanderbilt University , 4226 Stevenson Center, Nashville, Tennessee 37235, United States.

Analytical Chemistry
|June 24, 2014
PubMed
Summary
This summary is machine-generated.

Backscattering interferometry (BSI) offers a faster, more sensitive method for quantifying lung cancer biomarkers in patient serum compared to ELISA. This advancement could accelerate the clinical translation of new diagnostic tests for personalized medicine.

More Related Videos

Biomolecular Detection employing the Interferometric Reflectance Imaging Sensor IRIS
11:04

Biomolecular Detection employing the Interferometric Reflectance Imaging Sensor IRIS

Published on: May 3, 2011

14.3K
High-speed Continuous-wave Stimulated Brillouin Scattering Spectrometer for Material Analysis
07:55

High-speed Continuous-wave Stimulated Brillouin Scattering Spectrometer for Material Analysis

Published on: September 22, 2017

9.7K

Related Experiment Videos

Last Updated: Apr 27, 2026

High Speed Sub-GHz Spectrometer for Brillouin Scattering Analysis
13:31

High Speed Sub-GHz Spectrometer for Brillouin Scattering Analysis

Published on: December 22, 2015

14.6K
Biomolecular Detection employing the Interferometric Reflectance Imaging Sensor IRIS
11:04

Biomolecular Detection employing the Interferometric Reflectance Imaging Sensor IRIS

Published on: May 3, 2011

14.3K
High-speed Continuous-wave Stimulated Brillouin Scattering Spectrometer for Material Analysis
07:55

High-speed Continuous-wave Stimulated Brillouin Scattering Spectrometer for Material Analysis

Published on: September 22, 2017

9.7K

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Clinical Diagnostics

Background:

  • Personalized medicine relies on accurate biomarker quantification in patient samples for early disease detection and treatment monitoring.
  • Current methods face limitations in sensitivity and speed, hindering the clinical translation of potential biomarkers.
  • A bottleneck exists in the rapid validation of biomarker candidates for clinical application.

Purpose of the Study:

  • To quantitatively compare backscattering interferometry (BSI) with ELISA for biomarker validation.
  • To assess the sensitivity and efficiency of BSI for lung cancer biomarkers Cyfra 21-1 and Galectin-7.
  • To determine if BSI can overcome current limitations in biomarker assay development.

Main Methods:

  • Analytical validation study comparing BSI and ELISA using spiked serum for calibration.
  • Evaluation of two lung cancer biomarkers: Cyfra 21-1 and Galectin-7.
  • Analysis of blinded patient serum samples using both BSI and ELISA.

Main Results:

  • BSI demonstrated significantly lower limits of quantification (LOQ) for both biomarkers compared to ELISA.
  • LOQ for Cyfra 21-1: 230 pg/mL (BSI) vs. 4000 pg/mL (ELISA).
  • LOQ for Galectin-7: 13 pg/mL (BSI) vs. 500 pg/mL (ELISA).
  • BSI required 5.5-fold less sample volume and offered faster analysis.
  • Excellent day-to-day reproducibility (<15% CV for BSI).

Conclusions:

  • BSI provides a rapid, sensitive, and reproducible platform for analytical validation of serum biomarkers.
  • The BSI technology has the potential to significantly impact and alleviate the bottleneck in biomarker validation for clinical translation.
  • BSI offers improved analytical figures of merit over ELISA for biomarker quantification.